Mackay Memorial Hospital
Taipei, Taiwan
NCT Number: NCT03099629
The purpose of this study is to investigate the effectiveness of inspiratory muscle training (IMT) on respiratory performance in patients with esophageal cancer during combined modality therapy.
Looking for future studies?
Notify Me20 year and older
All sexes
Interventional
Not applicable
Taipei, Taiwan
Background and Purpose: Incidence rates of esophageal cancer remain high in Eastern Asia. In 2012, esophageal cancer was the 9th leading cause of cancer deaths in Taiwan. Whether surgical resection is possible, combined modality therapy is usually required for the treatment of esophageal cancer. In clinical observation, patients underwent combined modality therapy usually demonstrated respiratory muscle dysfunction which might further impair physical activity and quality of life. The purpose of this study is to investigate the effectiveness of inspiratory muscle training (IMT) on respiratory performance in patients with esophageal cancer during combined modality therapy.
Methods: This is a prospective interventional study design. A total of 45 patients with newly diagnosed esophageal cancer will be recruited from the Mackay Memorial Hospital. All tests will be performed at baseline (prior to cancer treatment), weekly during treatment, prior to surgery, and one month after surgery. Tests will include demographic data collection, respiratory muscle performance (maximal inspiratory and expiratory pressure tests combined with diaphragmatic surface electromyography, and pulmonary functional test), dyspnea, and the functional exercise test (6-min walk test). IMT will start with an intensity of 30% of maximal inspiratory pressure, 15 times/set, 3 sets/day, 7 days/week and training will continue until surgery is scheduled or 2 weeks after the completion of treatment if surgery is not suitable. Repeated measure ANOVA will be used for analyzing difference of parameters among various time points.
Clinical relevance: The results of this study will help to better understand the clinical beneficial effects (e.g., better functional capacity) of an added inspiratory muscle training during combined modality therapy in patients with esophageal cancer.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
inspiratory muscle training will start with an intensity of 30% of maximal inspiratory pressure, 15 times/set, 3 sets/day, 7 days/week and training will continue until surgery is scheduled or 2 weeks after the completion of treatment if surgery is not suitable.
Time frame: Baseline and weekly during CCRT treatment (for a total of 4-5 weeks)
Change from baseline MIP at the end of each week's CCRT treatment
Time frame: Baseline and weekly during CCRT treatment (for a total of 4-5 weeks)
Change from baseline MEP at the end of each week's CCRT treatment
Time frame: Baseline and weekly during CCRT treatment (for a total of 4-5 weeks)
Change from baseline EMGdi at the end of each week's CCRT treatment
Time frame: Baseline and weekly during CCRT treatment (for a total of 4-5 weeks)
Change from baseline FEV1 at the end of each week's CCRT treatment
Time frame: Baseline and weekly during CCRT treatment (for a total of 4-5 weeks)
Change from baseline FVC at the end of each week's CCRT treatment
Time frame: Baseline and weekly during CCRT treatment (for a total of 4-5 weeks)
Change from baseline 6-minute walking distance at the end of each week's CCRT treatment
Time frame: Baseline and weekly during CCRT treatment (for a total of 4-5 weeks)
Change from baseline Modified Borg Dyspnea score at the end of each week's CCRT treatment
Mackay Memorial Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00183898
Digestive System Diseases, Digestive System Neoplasms
Los Angeles, California, United States
View Trial DetailsNCT00341276
Digestive System Diseases, Digestive System Neoplasms
Taiyuan, China
View Trial DetailsNCT00342654
Digestive System Diseases, Digestive System Neoplasms
Beijing, China
View Trial DetailsNCT05538195
Colon Cancer, Colonic Diseases
Henan, China
View Trial Details